Childhood asthma in the under five age group: Diagnosis and treatment;Asthme de l'enfant avant 5 ans: Diagnostic et traitement

Revue des Maladies Respiratoires

Volumn 16, Issue 1, 1999, Pages 17-27

  Le Clainche, L ^a   Timsit, S ^a   Rigourd, V ^a   Scheinmann, P ^a   De Blic, J ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Asthma of childhood; Asthma of infancy; Inhaled corticosteroid therapy; Nebulisers; Spacer devices

Indexed keywords

BECLOMETASONE DIPROPIONATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; FENOTEROL; FLUNISOLIDE; FORMOTEROL FUMARATE; IPRATROPIUM BROMIDE; NEDOCROMIL; NEDOCROMIL SODIUM; OXITROPIUM BROMIDE; PIRBUTEROL; PIRBUTEROL ACETATE; SALBUTAMOL; SALMETEROL; SALMETEROL XINAFOATE; TERBUTALINE;

ASTHMA; CHILDHOOD DISEASE; CORTICOSTEROID THERAPY; DIAGNOSTIC APPROACH ROUTE; DISEASE SEVERITY; HEALTH EDUCATION; HUMAN; NEBULIZATION; PATIENT COMPLIANCE; PREVALENCE; REVIEW; RISK MANAGEMENT; TREATMENT PLANNING;

ASTHMA; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; HUMANS; INFANT;

EID: 0032987590     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (66)

1. RAHERISON C, TUNON DE LARA JM et al. : Prévalence de l'asthme chez l'enfant. Rev Mal Respir 1997;14:4S33-4S39.
2. SCHEINMANN P, DE BLIC J, DELACOURT C, LE BOURGEOIS M, PAUPE J : L'enfant asthmatique. Rev Prat 1992;42:2437-46.
3. JAFFUEL D, DEMOLY P, DHIVERT-DONNADIEU H, BOUSQUET J, MICHEL FB, GODARD PH : Epidémiologie et génétique de l'asthme : épidémiologie descriptive et analytique des facteurs environnementaux. Rev Mal Respir 1996;13:455-65.
4. SEARS MR : Descriptive épidemiology of asthma. Lancet 1997;350(suppl II): 1-4.
5. PLATTS-MILLS TAE : Asthma among inner city children. Pediatr Pulmonol 1997;24:231-3.
6. CLÉMENT A : Grands syndromes inflammatoires de l'enfant : Asthme. In : Journées parisiennes de pédiatrie. Paris : Médecine-Sciences, Flammarion. 1997:123-8.
7. BARNES PJ, KARIN M : Nuclear factor-kB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997;336:1066-71.
8. VAN HERWERDEN L, HARRAP SB, WONG ZYH et al. : Linkage of high-affinity IgE receptor gene with bronchila hyperreactivity, even in absence of atopy. Lancet 1995;346:1262-5.
9. POSTMA DS, BLEECKER ER, AMELUNG PJ et al. : Genetic susceptibility to asthma: bronchial hyperresponsiveness coinherited with a major gene atopy. N Engl J Med 1995;333:894-900.
10. TABACHNIK E, LEVISON H : Infantile bronchial asthma. J Allergy Clin Immunol 1981;67:339-47.
11. MARTINEZ FD, WRIGHT AL, TAUSSIG LM, HOLBERG CJ, HALONEN M, MORGAN WJ and the GROUP HEALTH MEDICAL ASSOCIATES : Asthma and wheezing in the first six years of life. N Engl J Med 1995;332:133-8.
12. DE BLIC J : Asthme du nourrisson. In : De Blic J, Scheinmann P, L'asthme. Progrès en pédiatrie, Paris, Doin éditeurs, 1995:102-20.
13. HOGG C, BUSH A : Childhood asthma - all that wheezes is not inflammation. Clin Exp Allergy 1997;27:991-4.
14. SEARS MR, BURRONS B, FLANNERY EM et al. : Relation between airway responsiveness and serum IgE in children with asthma and in apparently normal children. N Engl J Med 1991;325:1067-71.
15. PAUPE J : Tests biologiques. In : De Blic J, Scheinmann P, L'asthme. Progrès en pédiatrie, Paris, Doin éditeurs, 1995:181-9.
16. DELACOURT C, LABBE D, VASSAULT A et al. : Sensitization to inhalant allergens is predictive for the development of asthma in wheezing infants. Allergy 1994;49:843-7.
17. BARBATO A, MAGAROTTO M, CRIVELLARO M et al. : Use of paediatric bronchoscope, flexible and rigid, in 51 european centres. Eur Respir J 1997;10:1761-6.
18. HARDING SM, RICHTER JE : The role of gastrooesophageal reflux in chronic cough and asthma. Chest 1997;111:1389-402.
19. DUCHARME FM, DAVIS GM : Measurement of respiratory resistance in the emergency department - Feasibility in young children with acute asthma. Chest 1997;111:1519-25.
20. WARNER JO, NASPITZ CK, CROPP GJA : Third international pediatric consensus statement on the management of childhood asthma. Pediatr Pulmonol 1998;25:1-17.
21. WILDHABER JH, DEVADASON SG, EBER E et al. : Effect of electrostatic charge, flow, delay, and multiple actuations on the in vitro delivery of salbutamol from different small volume spacers for infants. Thorax 1996;51:985-8.
22. BISGAARD H, ANHOJ J, KLUG B, BERG E : A non-electrostatic spacer for aerosol delivery. Arch Dis Child 1995;73:226-30.
23. AGERDOFT L, PEDERSEN S : Influence of spacer device on drug delivery to young children with asthma. Arch Dis Child 1994;71:217-20.
24. WILDHABER JH, DEVADASON SG, HAYDEN MJ, EBER E, SUMMERS QA, LESOUEF PN : Aerosol delivery to wheezy infants: a comparison between a nebulizer and two small volume spacers. Pediatr Pulmonol 1997;23:212-6.
25. PARKIN PC, SAUNDERS NR, DIAMOND SA, WINDERS PM, MACARTHUR C : Randomised trial spacer u nebuliser for acute asthma. Arch Dis Child 1995;72:239-40.
26. LODRUP CARLSEN KC, NIKANDER K, CARLSEN KH : How much nebulised budesonide reaches infants and toddlers. Arch Dis Child 1992;67:1077-9.
27. TAL A, GOLAN H, GRAUER N, AVIRAM M, ALBIN D, QUASTEL MR : Deposition pattern of radiolabeled salbutamol inhaled from a metered-dose inhaler by means of spacer with mask in young children with airway obstruction. J Pediatr 1996;128:479-84.
28. FOK TF, MONKMAN S, DOLOVICH M et al. : Efficiency of aerosol medication delivery from a metered-dose ihnaler versus jet nebulizer in infants with bronchopulmonary dysplasia. Pediatr Pulmonol 1996;21:301-9.
29. MALLOL J, RATTRAY S, WALKER G, COOK D, ROBERTSON CF : Aerosol deposition in infants with cystic fibrosis. Pediatr Pulmonol 1996;21:276-81.
30. COGSWELL JJ, SIMPKISS MJ : Nebulised sodium cromoglycate in recurrently wheezy preschool children. Arch Dis Child 1985;60:736-8.
31. WENNERGREN G, NORDVALL SL, HEDLIN G, MÖLLER C, WILLE S, NILSSON EA : Nebulized Budesonide for the treatment of moderate to severe asthma in infants and toddlers. Acta Paediatr 1996;85:183-9.
32. NOBLE V, RUGGINS V, EVERARD ML, MILNER AD : Inhaled budesonide for chronic wheezing under 18 months of age. Arch Dis Child 1992;67:285-8.
33. PRENDIVILLE A, GREEN S, SILVERMAN M : Hypoxemia in wheezy infants after bronchodilatator treatment. Arch Dis Child 1987;62:997-1000.
34. PRENDIVILLE A, GREEN S, SILVERMAN M : Paradoxical response to nebulised salbutamol in wheezy infants, assessed by partial expiratory flow-volume curves. Thorax 1987;42:86-91.
35. AZEVEDO I, DE BLIC J, SCHEINMANN P, VARCAFTIG BB, BACHELET M : Enhanced Arachidonic Acid metabolism in alveolar macrophages from wheezy infants. Am J Respir Crit Care Med 1995;152:1208-14.
36. AZEVEDO I, DE BLIC J, DUMAREY CH, SCHEINMANN P, VARGAFTIG BB, BACHELET M : Increased release of tumor necrosis factor-alpha by alveolar macrophages from wheezy infants. Eur Respir J 1997;70:1767-73.
37. DE BLIC J, DELACOURT C, LE BOURGEOIS M et al. : Efficacy of nebulized budesonide in treatment of severe infantile asthma: a double blind study. J Allergy Clin Immunol 1996;98:14-20.
38. VAN BEVER HP, SCHUDDINCK L, WOJCIECHOWSKI M, STEVENS WJ : Aerosolized Budesonide in asthmatic infants: a double blind study. Pediatr Pulmonol 1990;9:177-80.
39. ILANGOVAN P, PEDERSEN S, GODFREY S, NIKANDER K, NOVISKI N, WARNER JO : Treatment of severe steroid dependent preschool asthma with nebulized Budesonide suspension. Arch Dis Child 1993;68:356-9.
40. BISGAARD H, PEDERSEN S : Safety of treatment. Eur Respir J 1996;9(Suppl 21): 28s-34s.
41. PEDERSEN S, O'BYRNE P : A comparison of the efficacy and safety of inhaled corticosteroids in asthma. Allergy 1997;52(Suppl 39): 1-34.
42. HAAHTELA T, JÄRVINEN M, KAVA T et al. : Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med 1994;331:700-5.
43. AGERTOFT L, PEDERSEN S : Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med 1994;88:373-81.
44. PEDERSEN S, WARNER JO, PRICE JF : Debate : early use of inhaled steroids in children with asthma. Clin Exp Allergy 1997;27:995-1001.
45. BOULET LP, LAVIOLETTE M, TURCOTTE H et al. : Bronchial subepithelial fibrosis correlates with airway responsiveness to metacholine. Chest 1997:112:45-52.
46. PEDERSEN S : Asthma: what needs to be assessed? Eur Respir Rev 1997;7:352-5.
47. LAITINEN LA, LAITINEN A, HAAHTELA T : A comparative study of the effects of an inhaled corticosteroid, budesonide, and a β2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomized, double-blind, parallel-group controlled trial. J Allergy Clin Immunol 1992;90:32-42.
48. TURKTAS I, DEMIRSOY S, KOC E, GÖKCORA N, ELBERG S : Effects of inhaled steroid treatment on serum eosinophilic cationic protein (ECP) and low affinity receptor for IgE (Fc e RII/sCD23) in childhood bronchial asthma. Arch Dis Child 1996;75:314-8.
49. CONNETT GJ, WARDE C, WOOLER E, LENNEY W : Use of budesonide in severe asthmatics aged 1-3 years. Arch Dis Child 1993;69:351-5.
50. BOE J, BAKKE P, RODOLEN T, SKOVLUND E, GULSVIK A : High-dose inhaled steroids in asthmatics: moderate efficacy gain and suppression of the hypothalamic-pituitary-adrenal (HPA) axis. Eur Respir J 1994;7:2179-84.
51. AGERTOFT L, PEDERSEN S : Bone mineral density in children with asthma receiving long-term treatment with inhaled Budesonide. Am J Respir Crit Care Med 1998;157:178-83.
52. NATIONAL ASTHMA EDUCATION and PREVENTION PROGRAM : Highlights of the expert panel report 2 : Guidelines for the diagnosis and management of asthma. Bethesda, MD. United States Department of Health and Human Services, Public Health Service, National Institutes of Health, National Heart, Lung, and Blood Institute; 1997.
53. VERBERNE AAPH, DE JONGSTE JC : The role of inhaled long acting bronchodilatator therapy. Eur Respir Rev 1996;6:199-203.
54. TAN RA, SPECTOR SL : Antileukotriene agents. Current Opinion in Pulmonary Medicine 1997;3:215-20.
55. HOLT PG, SLY PD : Allergic respiratory disease: strategic targets for primary prevention during childhood. Thorax 1997;52:1-4.
56. KUEHR J, FRISCHER T, MELNERT R et al. : Mite allergen exposure is a risk for the incidence of specific sensitization. J Allergy Clin Immunol 1994;94:44-52.
57. HIDE DW, MATTHEWS S, TARIQ S, ARSHAD SH : Allergen avoidance in infancy and allergy at 4 years of age. Allergy 1996;51:89-93.
58. VON MUTIUS E : Towards prevention. Lancet 1997;350(suppl II): 14-7.
59. HIDE DW : Strategies for the prevention of atopic asthma. Pediatr Allergy Immunol 1996;7(Suppl 9): 117-22.
60. KOLLER DY, WOJNAROWSKI C, HERKNER KR et al. : High levels of eosinophilic cationic protein in wheezing infants predict the development of asthma. J Allergy Clin Immunol 1997;99:752-6.
61. CHILMONCZYK BA, SALMUN LM, MEGATHLIN KN et al. : Association between exposure to environmental tobacco smoke and exacerbations of asthma in children. N Engl J Med 1993;328:1665-9.
62. SOYSETH V, KONGERUD J, BOE J : Postnatal maternal smoking increases the prevalence of asthma but not of bronchial hyperresponsiveness or atopy in their children. Chest 1995;107:389-94.
63. WENNERGREN G : Impact of viral infection on bronchial hyperresponsiveness. Pediatr Allergy Immunol 1996;7(Suppl 9): 10-3.
64. NICHOLSON KG, NGUYEN-VAN-TAM JS, AHMED AH et al. : Randomised placebo-controlled crossover trial on effect of inactivated influenza vaccine on pulmonary function in asthma. Lancet 1998;351:326-31.
65. GIBSON NA, FERGUSON AE, AITCHISON TC, PATON JY : Compliance with inhaled asthma medication in preschool children. Thorax 1995;50:1274-9.
66. MILGROM H, BENDER B : Nonadherence with asthma regimen. Pediatr Ashma Allergy Immunol 1997;11:3-8.